Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study

BMC Pulmonary Medicine

Volumn 13, Issue 1, 2013, Pages

  Zhong, Nanshan ^a   Lin, Jiangtao ^b   Mehta, Parthiv ^c   Ngamjanyaporn, Pintip ^d   Wu, Tzu Chin ^e   Yunus, Faisal ^f  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c Mehta's Hospital and Cardiopulmonary Care Centre   (India)

^d MAHIDOL UNIVERSITY   (Thailand)

^e CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Asthma control; Asthma management; Budesonide formoterol; Symbicort maintenance and reliever therapy

Indexed keywords

ANTIASTHMATIC AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FLUTICASONE; SALBUTAMOL; SYMBICORT SMART; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASIA; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; ASTHMA QUALITY OF LIFE QUESTIONNAIRE; DISEASE DURATION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; QUALITY OF LIFE; SYMPTOM;

ADULT; ASIA; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SLEEP; TREATMENT OUTCOME;

EID: 84875690350     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-13-22     Document Type: Article

References (29)

1. Montuschi P. Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues. Front Pharmacol 2011, 2:35. 3139104, 21808620.
2. Sin DD, Man J, Sharpe H, Gan WQ, Man SF. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. JAMA 2004, 292(3):367-376. 10.1001/jama.292.3.367, 15265853.
3. Paris J, Peterson EL, Wells K, Pladevall M, Burchard EG, Choudhry S, Lanfear DE, Williams LK. Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbations. Ann Allergy Asthma Immunol 2008, 101(5):482-487. 10.1016/S1081-1206(10)60286-4, 2646829, 19055201.
4. Mintz M, Gilsenan AW, Bui CL, Ziemiecki R, Stanford RH, Lincourt W, Ortega H. Assessment of asthma control in primary care. Curr Med Res Opin 2009, 25:2523-2531. 10.1185/03007990903218655, 19708765.
5. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004, 114:40-47. 10.1016/j.jaci.2004.04.042, 15241342.
6. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2010, Available from: http://www.ginasthma.org/ (accessed October 2011).
7. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline Available at: http://www.brit-thoracic.org.uk/guidelines/asthma-guidelines.aspx; 2010 [accessed October 2010].
8. Postma DS, Kerstjens HA, ten Hacken NH. Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?. Naunyn Schmiedebergs Arch Pharmacol 2008, 378(2):203-215. 10.1007/s00210-008-0302-y, 2493602, 18500509.
9. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006, 368:744-753. 10.1016/S0140-6736(06)69284-2, 16935685.
10. Rabe KF, Pizzichini E, Ställberg B, Romero S, Balanzat AM, Atienza T, Lier PA, Jorup C. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest 2006, 129:246-256. 10.1378/chest.129.2.246, 16478838.
11. Zetterström O, Buhl R, Mellem H, Perpiñá M, Hedman J, O'Neill S, Ekström T. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J 2001, 18:262-268. 10.1183/09031936.01.00065801, 11529282.
12. Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997, 337:1405-1411. 10.1056/NEJM199711133372001, 9358137.
13. Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med 2007, 101:2437-2446. 10.1016/j.rmed.2007.07.014, 17905575.
14. Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin 2004, 20:1403-1418. 10.1185/030079904X2051, 15383189.
15. Bateman ED, Harrison TW, Quirce S, Reddel HK, Buhl R, Humbert M, Jenkins CR, Peterson S, Ostlund O, O'Byrne PM, Sears MR, Eriksson GS. Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res 2011, 12:38. 10.1186/1465-9921-12-38, 3082240, 21463522.
16. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2007, Available from: http://www.ginasthma.org/documents/5/documents_variants/34 (accessed April, 2013).
17. Juniper EF, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14(4):902-907. 10.1034/j.1399-3003.1999.14d29.x, 10573240.
18. Juniper EF, As B, Cox FM, Ferrie PJ, King DR. Validation of a standardised version of the Asthma Quality of Life Questionnaire. Chest 1999, 115:1265-1270. 10.1378/chest.115.5.1265, 10334138.
19. Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the asthma quality of life questionnaire. Chest 1999, 115(5):1265-1270. 10.1378/chest.115.5.1265, 10334138.
20. Juniper EF, Stahl E, O'Byrne PM. Minimal important difference for the asthma control questionnaire. Resp Crit Care Med 2001, 163(5):A642.
21. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005, 26(2):319-338. 10.1183/09031936.05.00034805, 16055882.
22. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J 1993, 6(suppl. 16):5-40.
23. Louis R, Joos G, Michils A, Vandenhoven G. A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management. Int J Clin Pract 2009, 63(10):1479-1488. 10.1111/j.1742-1241.2009.02185.x, 2780558, 19769705.
24. Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database Syst Rev 2005, 9(4):CD005535. Review. Update in: Cochrane Database Syst Rev. 2010;(5):CD005535.
25. Frois C, Wu EQ, Ray S, Colice GL. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. Clin Ther 2009, 31(12):2779-2803. 10.1016/j.clinthera.2009.12.021, 20110019.
26. Buhl R, Vogelmeier C. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. Curr Med Res Opin 2007, 23(8):1867-1878. 10.1185/030079907X210769, 17605896.
27. Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev 2010, 19(4):CD005533. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD005533.
28. Sears MR, Radner F. Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials. Respir Med 2009, 103:1960-1968. 10.1016/j.rmed.2009.08.007, 19815402.
29. Cates CJ, Lasserson TJ. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2010, 1:CD007694.